Cystatin C compared to serum creatinine as a marker of acute kidney injury in critically ill neonates
- 27 June 2020
- journal article
- research article
- Published by Springer Nature in Pediatric Nephrology
- Vol. 36 (1) , 181-186
Abstract
Background Acute kidney injury (AKI) is one of the most common causes of neonatal morbidity and mortality. Diagnosing AKI in neonates is challenging as it lacks specific signs, symptoms, and biomarkers. However, detecting AKI in critically ill neonates is crucial to determine appropriate management and prevent complications. Cystatin C (CysC) has been recognized as a superior kidney biomarker reflecting kidney function in neonates. The objective of this study is to evaluate the diagnostic value of CysC as an AKI biomarker in critically ill neonates. Methods We performed a diagnostic test between cystatin C-based estimated glomerular filtration rate (eGFR-CysC) and serum creatinine-based estimated glomerular filtration rate (eGFR-SCr) as the gold standard to diagnose AKI in 135 critically ill neonates treated in Cipto Mangunkusumo National Hospital from July 2017 to January 2018. Results Prevalence of AKI was 23.7% predominantly in neonates with a very preterm gestational age, low birthweight, probable sepsis, and those receiving invasive oxygen therapy or nephrotoxic drugs. The proportion of AKI based on neonate RIFLE criteria was 72.7% risk, 18.9% injury, and 9% failure. eGFR-CysC had the following parameters: sensitivity, 84.8%; specificity, 61.8%; PPV, 41.8%; NPV, 89.7%; LR(+), 2.2; LR(−), 0.24; and accuracy, 67.4%. The AUROC for CysC was 84.9%. The optimal cut-off value for CysC was 1.605 mg/l. Conclusions CysC may be used as a screening biomarker of AKI in critically ill neonates; yet, it was not superior to serum creatinine. Graphical abstractKeywords
This publication has 29 references indexed in Scilit:
- Defining reduced urine output in neonatal ICU: importance for mortality and acute kidney injury classificationNephrology Dialysis Transplantation, 2013
- Serum cystatin C predicts acute kidney injury in preterm neonates with respiratory distress syndromePediatric Nephrology, 2012
- Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin CKidney International, 2012
- Risk factors associated with acute kidney injury in extremely low birth weight (ELBW) infantsPediatric Nephrology, 2011
- Cystatin C in acute kidney injuryCurrent Opinion in Critical Care, 2010
- Acute kidney injury in critically ill newborns: What do we know? What do we need to learn?Pediatric Nephrology, 2009
- Determination of reference values for plasma cystatin C and comparison with creatinine in premature infantsPediatric Nephrology, 2008
- Biomarkers of Acute Kidney InjuryAnnual Review of Pharmacology and Toxicology, 2008
- Cystatin C versus creatinine as a marker of glomerular filtration rate in the newbornWiener klinische Wochenschrift, 2006
- Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney functionNephrology Dialysis Transplantation, 2006